The β-catenin-LINC00183-miR-371b-5p-Smad2/LEF1 axis promotes adult T-cell lymphoblastic lymphoma progression and chemoresistance

Abstract

Background High-intensity chemotherapy regimens are often used in adult T-cell lymphoblastic lymphoma (T-LBL) patients. Nevertheless, the response rate remains unsatisfactory due to emergence of chemoresistance. Growing evidence has shown that long non-coding RNAs (lncRNAs) are involved in tumor progression and chemoresistance. Herein, we investigated the potential role of lncRNAs in T-LBLs. Methods RNAseq was used to screen and identify candidate lncRNAs associated with T-LBL progression and chemoresistance. Luciferase reporter assay was used to examine the binding of miR-371b-5p to the 3’UTR of Smad2 and LEF1, and the binding of TCF-4/LEF1 to the promoter of LINC00183. Chromatin immunoprecipitation assay was undertaken to analyze the connection between LEF1 and the LINC00183 promoter region. RNA immunoprecipitation assays were used to explore the mechanism whereby LINC00183 regulated miR-371b-5p. MTT and flow cytometry assays were used to measure apoptosis of T-LBL cells. Results LINC00183 was upregulated in T-LBL progression and chemoresistant tissues in both the Sun Yat-sen University Cancer Center dataset and the First Affiliated Hospital of Anhui Medical University dataset. High expression of LINC00183 was correlated with poorer overall survival and progression-free survival of T-LBL patients compared to those with low expression of LINC00183. Furthermore, miR-371b-5p was negatively regulated by LINC00183. In vivo and in vitro assays showed that LINC00183-mediated T-LBL chemoresistance depended on miR-371b-5p expression. The direct binding of miR-371b-5p to Smad2 and LEF1 was verified by luciferase assays. It was shown that TCF4/LEF1 could bind to the LINC00183 promoter site and increase its transcript level. Downregulation of miR-371b-5p led to increased expression of Smad2/LEF1, and in turn increased LINC00183 expression. Additionally, phospho-Smad2 promotes nuclear translocation of β-catenin, LINC00183 downregulation decreased chemoresistance induced by β-catenin and TGF-β1 in T-LBL cells. Conclusion We unraveled a β-catenin-LINC00183-miR-371b-5p-Smad2/LEF1 feedback loop that promotes T-LBL progression and chemoresistance, indicating that LINC00183 may serve as a potential therapeutic target in T-LBLs.

Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer

“…Extensive evidence indicates that the nuclear or cytoplasmic localization of lncRNAs is associated with the cellular functions of lncRNAs [ 17 ]. lncRNAs can interact with miRNAs, mRNAs, and proteins to regulate post-transcriptional modification in the cytoplasm [ 37 , 38 ]. However, lncRNAs recruit transcription factors and bind promoter regions to modulate gene transcription in the nucleus [ 39 ].…”

SMAD Proteins in TGF-β Signalling Pathway in Cancer: Regulatory Mechanisms and Clinical Applications

“…Among the 849 patients with endometrial cancer, 52 patients had mutations in SMAD2 including 41 missense mutations and 11 truncating mutations. Forty-one patients had mutations in SMAD3 and 36 patients had mutations in SMAD4 [127]. The tumour suppressor function of SMAD2/3 in the endometrium was found to be mediated by the PI3K/PTEN/AKT signalling pathway, which has an important role in regulating epithelial cell homeostasis and interfering with the effect of both pathways on endometrial carcinogenesis.…”

Interactions between genistein and Wnt pathway in colon adenocarcinoma and early embryos

“…Inappropriate activation of the Wnt pathway has been associated with uncontrolled cell proliferation, invasion, and metastasis in various cancer subtypes. Genistein has a demonstrable ability to interfere with the Wnt pathway through various mechanisms [ [10] , [11] , [12] , [13] ]. One key aspect is its ability to modulate the expression of essential components of the pathway, such as β-catenin.…”